The enterprise Formycon from Martinsried near Munich developed a drug that Coronavirus should fight. Because even if herd immunity is achieved at some point in Germany and worldwide through the corona vaccination, the virus will still exist and therefore also Infections. Especially people who are not protected – do not get vaccinated or do not develop enough antibodies – can then still become infected.- The clinical study at Formycon from Martinsried near Munich is already running. Again Bavarian broadcast on BR24 reports, according to Carsten Brockmeyer, CEO of Formycon AG, the drug is “one of the first to be developed specifically against Covid-19”. Against the Mutants According to Brockmeyer, the drug “FYB207” is particularly effective against the coronavirus.-
It costs several million euros to bring a new drug onto the market. Research and development is very costly. 200 million According to Brockmeyer, it will cost around euros until the corona drug from Munich is ready. The state of Bavaria now has funding for this 11 million announced for the Munich company. Overall, the federal government wants to issue a total of 350 million euros in funding for Covid drug research.
